# Endometriosis Demands Urgent Action, BBC Presenter Emma Barnett Warns

Emma Barnett has launched a public campaign demanding government action on endometriosis, a chronic condition affecting roughly one in ten women. The BBC presenter, who lives with the disease herself, collected testimonies from affected women to illustrate how the condition disrupts careers, relationships, and daily functioning.

Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus, causing severe pain during menstruation and often during intercourse or bowel movements. The condition frequently leads to infertility. Despite affecting millions of women, endometriosis remains chronically under-researched and under-diagnosed.

Barnett's campaign highlights a troubling gap between disease prevalence and medical attention. Women with endometriosis report waiting years for diagnosis, with many dismissed by healthcare providers who minimize their symptoms. Some describe experiencing debilitating pain that forces them to miss work or abandon activities they enjoy.

The testimonies reveal how endometriosis intersects with broader healthcare inequities. Women describe being told their pain is "just bad periods" or psychological rather than physical. This dismissal delays treatment and compounds suffering during years when early intervention might improve outcomes.

Current treatment options remain limited. Hormonal contraceptives can reduce pain for some women. Surgery to remove endometrial tissue offers temporary relief but doesn't guarantee permanent resolution. Hysterectomy remains a last resort, though it doesn't always eliminate pain from tissue outside the uterus.

Barnett is calling on UK ministers to prioritize endometriosis in health policy, improve medical training to ensure proper diagnosis, and fund research into better treatments. She argues that a condition affecting one in ten women deserves the same research investment and clinical attention given to other chronic diseases.

The campaign reflects growing momentum among patient advocates